Cover Image

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Zehetmayer, Sonja, Roig, Marta Bofill, Mougeni, Fabrice Lotola, Specht, Sabine, Hübner, Marc P., Posch, Martin
Format:	Preprint
Published:	2026
Subjects:	Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

On the inclusion of non-concurrent controls in platform trials with an interim analysis
by: Krotka, Pavla, et al.
Published: (2025)

Optimal allocation strategies in platform trials
by: Roig, Marta Bofill, et al.
Published: (2023)

Statistical modeling to adjust for time trends in adaptive platform trials utilizing non-concurrent controls
by: Krotka, Pavla, et al.
Published: (2024)

NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
by: Krotka, Pavla, et al.
Published: (2023)

Treatment-control comparisons in platform trials including non-concurrent controls
by: Roig, Marta Bofill, et al.
Published: (2024)

An exhaustive ADDIS principle for online FWER control
by: Fischer, Lasse, et al.
Published: (2023)

ADDIS-Graphs for online error control with application to platform trials
by: Fischer, Lasse, et al.
Published: (2023)

On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Selection Bias in Hybrid Randomized Controlled Trials using External Controls: A Simulation Study
by: Chiam, Han Chang, et al.
Published: (2025)

The Online Closure Principle
by: Fischer, Lasse, et al.
Published: (2022)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Stratification in Randomised Clinical Trials for Rare Diseases and Analysis of Covariance: Some Simple Theory and Recommendations
by: Senn, Stephen, et al.
Published: (2024)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
by: Sverdlov, Oleksandr, et al.
Published: (2025)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)

Graph Based, Adaptive, Multi Arm, Multiple Endpoint, Two Stage Design
by: Mehta, Cyrus, et al.
Published: (2025)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
by: DAngelo, Gina, et al.
Published: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

Two-stage Adaptive Design Cluster Randomised Trials
by: Watson, Samuel I., et al.
Published: (2026)

ROSE: Randomized Optimal Selection Design for Dose Optimization
by: Wang, Shuqi, et al.
Published: (2025)

Estimands for Early Phase Dose Optimization Trials in Oncology
by: Mukherjee, Ayon, et al.
Published: (2025)

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
by: Zhan, Tianyu
Published: (2023)

ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024)

Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials
by: Willard, James, et al.
Published: (2024)

A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
by: Sun, Hao, et al.
Published: (2025)

TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
by: Sun, Hao, et al.
Published: (2025)

Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
by: Willard, James, et al.
Published: (2023)

Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology
by: Sun, Hao, et al.
Published: (2024)

Covariate adjustment for linear models in estimating treatment effects in randomised clinical trials. Some useful theory to guide simulation
by: Senn, Stephen, et al.
Published: (2025)

Enhancing Dose Selection in Phase I Cancer Trials: Extending the Bayesian Logistic Regression Model with Non-DLT Adverse Events Integration
by: Nizzardo, Andrea, et al.
Published: (2024)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability
by: Yang, Yunlong, et al.
Published: (2024)

Model-robust Inference for Seamless II/III Trials with Covariate Adaptive Randomization
by: Yi, Kun, et al.
Published: (2025)

TWICEBEE: A Two-stage Intra-patient Curve-free Bayesian Decision-Theoretic Dose Escalation Design
by: Bi, Dehua, et al.
Published: (2026)

BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
by: Chen, Kai, et al.
Published: (2024)

Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity
by: Makino, Kana, et al.
Published: (2025)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)

Bayesian Variable Selection on Small Sample Trial Data via Adaptive Posterior-Informed Shrinkage Prior
by: Kong, Lingxuan, et al.
Published: (2025)